HeadlineShine

GSK shares dive as weaker sales and mounting costs unnerve investors

The GuardianGSK shares dive as weaker sales and mounting costs unnerve investors
Image: The Guardian

British pharma company reports declining profits amid weaker vaccine sales and looming patent loss for blockbuster HIV drug Business live – latest updates Shares in GSK slid on Wednesday despite the UK drugmaker reporting better than expected financial…

Summary from The Guardian

Read the full story on The Guardian
React

More on Shares

See all →

More business

See all →

Top stories in the United Kingdom

See all →